We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SJNK icon
901
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.7B
$988K ﹤0.01%
31,900
+9,320
+41% +$288K
USNA icon
902
Usana Health Sciences
USNA
$275M
$985K ﹤0.01%
25,200
-10,000
-28% -$371K
AAP icon
903
Advance Auto Parts
AAP
$2.62B
$982K ﹤0.01%
+7,282
New +$902K
EWL icon
904
iShares MSCI Switzerland ETF
EWL
$2.31B
$982K ﹤0.01%
28,600
-7,600
-21% -$265K
SHLM
905
DELISTED
Schulman (A.) Inc
SHLM
$979K ﹤0.01%
+25,300
New +$910K
CACC icon
906
Credit Acceptance
CACC
$6.23B
$977K ﹤0.01%
7,934
-1,166
-13% -$154K
WTI icon
907
W&T Offshore
WTI
$623M
$977K ﹤0.01%
+59,700
New +$985K
ATW
908
DELISTED
Atwood Oceanics
ATW
$976K ﹤0.01%
18,600
-25,290
-58% -$1.25M
OVTI
909
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$972K ﹤0.01%
44,200
– –
ACAD icon
910
Acadia Pharmaceuticals
ACAD
$4.61B
$967K ﹤0.01%
42,816
-1,722
-4% -$36K
SFY
911
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
$966K ﹤0.01%
74,400
+18,900
+34% +$215K
HRL icon
912
Hormel Foods
HRL
$11.4B
$965K ﹤0.01%
39,108
-25,186
-39% -$609K
CDR
913
DELISTED
Cedar Realty Trust, Inc
CDR
$965K ﹤0.01%
23,394
+10,364
+80% +$418K
LOGI icon
914
Logitech
LOGI
$14.5B
$964K ﹤0.01%
74,000
+39,000
+111% +$528K
FNGN
915
DELISTED
Financial Engines, Inc.
FNGN
$963K ﹤0.01%
21,269
+3,888
+22% +$174K
WPG
916
DELISTED
Washington Prime Group Inc.
WPG
$960K ﹤0.01%
+5,694
New +$991K
KAI icon
917
Kadant
KAI
$3.14B
$956K ﹤0.01%
24,867
+400
+2% +$14.8K
PDCO
918
DELISTED
Patterson Companies, Inc.
PDCO
$952K ﹤0.01%
24,103
+1,635
+7% +$66.1K
REMY
919
DELISTED
REMY INTL INC NEW COMMON
REMY
$945K ﹤0.01%
40,459
-2,295
-5% -$55.7K
FR icon
920
First Industrial Realty Trust
FR
$8.14B
$942K ﹤0.01%
50,000
+10,000
+25% +$187K
DBS
921
DELISTED
Invesco DB Silver Fund
DBS
$942K ﹤0.01%
26,920
+3,850
+17% +$125K
NCI
922
DELISTED
Navigant Consulting, Inc.
NCI
$941K ﹤0.01%
53,900
-10,450
-16% -$181K
OME
923
DELISTED
Omega Protein
OME
$941K ﹤0.01%
68,800
– –
FRT icon
924
Federal Realty Investment Trust
FRT
$9.9B
$939K ﹤0.01%
7,763
+3
+0% +$354
RARE icon
925
Ultragenyx Pharmaceutical
RARE
$1.29B
$936K ﹤0.01%
20,852
– –
35 36
37
38 39

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.